Equities

Retractable Technologies Inc

Retractable Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.9335
  • Today's Change0.016 / 1.74%
  • Shares traded214.43k
  • 1 Year change-23.48%
  • Beta2.0486
Data delayed at least 15 minutes, as of May 24 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Retractable Technologies, Inc. is engaged in manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

  • Revenue in USD (TTM)40.20m
  • Net income in USD-7.80m
  • Incorporated1994
  • Employees148.00
  • Location
    Retractable Technologies Inc511 Lobo LaneLITTLE ELM 75068-5295United StatesUSA
  • Phone+1 (972) 294-1010
  • Fax+1 (972) 292-3600
  • Websitehttps://retractable.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neuraxis Inc2.46m-14.63m19.98m17.00------8.12-3.78-3.780.5432------------------87.67---594.57-----23.75-----8.37---163.78------
Agape ATP Corp1.37m-2.39m20.22m21.00--5.53--14.77-0.0312-0.03120.0180.04750.3949.4130.7965,188.57-68.48---94.72--64.84---173.78--4.99--0.0204---22.92---24.61------
BioSig Technologies Inc27.00k-25.25m20.34m4.00------753.21-3.24-3.240.0033-0.37760.008--1.746,750.00-728.65-269.73---363.1148.15---91,566.66-24,485.73---------93.71---6.52---9.58--
SANUWAVE Health Inc22.41m-17.26m21.32m31.00------0.9512-0.0267-0.02670.0238-0.04171.103.607.50722,838.70-84.54-136.54----71.6369.13-77.00-189.600.11930.0192----21.8461.61-150.72------
REMSleep Holdings Inc175.95k-1.80m22.87m6.00--33.78--129.97-0.0012-0.00120.00010.00050.08481.6911.20---86.95-152.40-108.40-317.98-411.78---1,025.38-2,317.521.63-18.540.0673---36.48--12.13--28.26--
Ekso Bionics Holdings Inc17.91m-14.24m23.63m70.00--1.67--1.32-0.9685-0.96851.200.77650.54231.653.38255,900.00-43.11-43.63-57.86-57.6750.4151.93-79.48-104.242.11-34.630.2937--41.5710.03-0.7825--3.69--
BioRegenx Inc22.24k-571.17k25.83m10.00------1,161.38-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
Femasys Inc1.05m-14.90m27.55m32.00--1.76--26.26-0.8567-0.85670.05880.70630.05490.49398.5832,785.00-77.93---86.46--65.35---1,420.27--8.02--0.3057---11.13---25.04------
Retractable Technologies Inc40.20m-7.80m27.95m148.00--0.2811--0.6953-0.2607-0.26071.343.330.21751.545.85271,589.10-4.1012.45-4.3014.5120.2540.82-18.8418.098.18-2.900.0145---54.025.55-249.46--17.42--
SeaStar Medical Holding Corp0.00-33.67m28.51m12.00---------1.07-1.070.00-0.05930.00----0.00-605.20-----------------4.39---------115.19------
Positron Corp1.24m-1.27m29.02m22.00------23.46-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Neuroone Medical Technologies Corp3.77m-12.80m29.99m16.00--7.44--7.96-0.5877-0.58770.16790.14640.5982.129.79235,460.60-203.24-172.88-269.30-274.7430.12---339.86-674.972.21--0.00--62.66---18.60------
Akili Inc1.95m-48.55m32.27m36.00--0.6425--16.57-0.6201-0.62010.02490.63810.0203--20.1928,647.06-50.58---57.34--56.11---2,492.04-----25.510.1835--419.50---212.48------
Co-Diagnostics Inc6.68m-38.89m33.78m155.00--0.4311--5.06-1.32-1.320.22682.510.06561.144.2643,083.48-38.195.77-39.936.1541.3482.24-582.3610.949.90--0.000.00-80.09179.54-148.15--101.27--
Harvard Apparatus Regenertv Tchnlgy Inc160.00k-8.08m35.07m10.00--195.26--219.20-0.5824-0.58240.01150.01260.0474----16,000.00-239.52-330.30-507.69-1,524.8877.50---5,053.13-35,138.840.2558--0.7407-------44.28---39.07--
Data as of May 24 2024. Currency figures normalised to Retractable Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

6.69%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 2024693.13k2.32%
Renaissance Technologies LLCas of 31 Mar 2024358.89k1.20%
BlackRock Fund Advisorsas of 31 Mar 2024273.23k0.91%
Bridgeway Capital Management LLCas of 31 Mar 2024149.53k0.50%
Geode Capital Management LLCas of 31 Mar 2024137.17k0.46%
WealthTrust Axiom LLCas of 31 Mar 2024116.53k0.39%
LPL Financial LLCas of 31 Mar 202475.50k0.25%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202473.80k0.25%
Citadel Securities LLCas of 31 Mar 202464.83k0.22%
SSgA Funds Management, Inc.as of 31 Mar 202459.80k0.20%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.